Quality Chinese medicinal materials defined in this document refer to those that are produced in accordance with the Good Practice for the Production of Chinese Medicinal Materials (GAP) and Good Practice for the Cultivation and Harvesting of Medicinal Plants (GACP) and other management regulations. The indicators of Chinese medicinal materials are higher than the requirements of the "Chinese Pharmacopoeia" (2020 edition), and the limit indicators such as exogenous pollutants and endogenous toxic substances are lower than the requirements of the "Chinese Pharmacopoeia" (2020 edition). The series of standards including this document also add exclusive technical methods according to specific varieties to formulate quality control standards that can reflect intrinsic quality. The quality Chinese medicinal material Codonopsis pilosula has increased the specifications of Codonopsis pilosula medicinal materials and the content of acetylene glycosides, determined 223 types of pesticide residues and maximum residue limits, and stipulated the limit indicators of sulfur dioxide and aflatoxin in Codonopsis pilosula medicinal materials.
T/CAQ 29005-2023 history
2023T/CAQ 29005-2023 Quality Chinese medicinal materials—Codonopsis radix